Ventyx Biosciences (VTYX) SEC Filings & 10K Form

$4.24
-0.11 (-2.53%)
(As of 04:28 PM ET)

Recent Ventyx Biosciences SEC Filings

DateFilerForm TypeView
04/16/2024
3:50 PM
Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:42 PM
NSV Partners III GP LLC (Reporting)
NSV Partners III LP (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
4:07 PM
Ventyx Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/05/2024
4:05 PM
Ventyx Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
11:52 AM
Flynn James E (Filed by)
Ventyx Biosciences (Subject)
Form SC 13G
04/03/2024
6:30 PM
Auster Martin (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
6:32 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
6:33 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
6:37 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
6:58 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2024
7:02 PM
Nuss John (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2024
7:07 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2024
6:00 PM
Auster Martin (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/29/2024
5:07 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
5:09 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
5:12 PM
Auster Martin (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2024
5:15 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
5:04 PM
NSV Investments I, L.P. (Filed by)
Ventyx Biosciences (Subject)
Form SC 13D/A
03/11/2024
8:01 AM
Ventyx Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
7:45 AM
Ventyx Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
3:28 PM
Point72 Asset Management, L.P. (Filed by)
Ventyx Biosciences (Subject)
Form SC 13G
02/14/2024
3:57 PM
CITADEL ADVISORS LLC (Filed by)
Ventyx Biosciences (Subject)
Form SC 13G/A
01/29/2024
3:00 PM
TANG CAPITAL PARTNERS LP (Filed by)
Ventyx Biosciences (Subject)
Form SC 13G
01/29/2024
2:26 PM
BlackRock Inc. (Filed by)
Ventyx Biosciences (Subject)
Form SC 13G
01/23/2024
4:23 PM
Ventyx Biosciences (Issuer)
White William Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
4:10 PM
Cadoret-Manier Onaiza (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
4:13 PM
HULME ALLISON (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
4:18 PM
Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:26 PM
Auster Martin (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:19 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:21 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:23 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:47 PM
Ventyx Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/21/2023
7:10 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
7:12 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
7:14 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
6:10 PM
Nuss John (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2023
6:15 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2023
6:22 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2023
4:27 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:30 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This Apple-like Innovator is Revolutionizing Healthcare (Ad)

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry
12/19/2023
4:21 PM
Auster Martin (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2023
4:25 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
8:09 AM
FMR LLC (Filed by)
Ventyx Biosciences (Subject)
Form SC 13G/A
12/07/2023
3:30 PM
Ventyx Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
3:57 PM
Ventyx Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:20 PM
Ventyx Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
4:15 PM
Ventyx Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2023
3:18 PM
Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
3:21 PM
NSV Partners III GP LLC (Reporting)
NSV Partners III LP (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
7:32 AM
NSV Partners III LP (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2023
5:17 AM
Ventyx Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
6:16 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2023
3:19 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2023
6:33 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2023
6:26 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
3:10 PM
Nuss John (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2023
6:16 PM
NSV Partners III GP LLC (Reporting)
NSV Partners III LP (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
6:19 PM
Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2023
3:28 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2023
3:31 PM
Auster Martin (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2023
3:21 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2023
3:25 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
1:16 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
12:51 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
12:10 PM
Nuss John (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2023
11:35 AM
Auster Martin (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/01/2023
3:45 PM
Sandborn William J. (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
5:54 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
5:57 PM
Sandborn William J. (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2023
2:07 PM
Luo Allison (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/04/2023
5:06 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2023
5:08 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2023
5:04 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Issuer)
Form 4/A
08/03/2023
2:28 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2023
2:50 PM
Nuss John (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2023
4:43 PM
NSV Partners III GP LLC (Reporting)
NSV Partners III LP (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2023
4:44 PM
Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2023
1:47 PM
Sandborn William J. (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/26/2023
5:51 PM
Auster Martin (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2023
9:24 AM
Auster Martin (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2023
6:07 PM
Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
Form 4/A
07/19/2023
6:10 PM
NSV Partners III GP LLC (Reporting)
NSV Partners III LP (Reporting)
Ventyx Biosciences (Issuer)
Form 4/A
07/19/2023
4:03 PM
NSV Investments I, L.P. (Filed by)
Ventyx Biosciences (Subject)
Form SC 13D/A
07/13/2023
8:25 PM
Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/13/2023
8:26 PM
NSV Partners III GP LLC (Reporting)
NSV Partners III LP (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2023
8:13 PM
NSV Partners III GP LLC (Reporting)
NSV Partners III LP (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2023
8:15 PM
Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2023
3:02 PM
NSV Investments I, L.P. (Filed by)
Ventyx Biosciences (Subject)
Form SC 13D/A
07/07/2023
1:41 PM
NSV Partners III LP (Reporting)
Ventyx Biosciences (Subject)
Form 144/A
07/07/2023
12:07 PM
NSV Partners III LP (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
This Apple-like Innovator is Revolutionizing Healthcare (Ad)

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry
07/06/2023
5:21 PM
Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
5:25 PM
NSV Partners III GP LLC (Reporting)
NSV Partners III LP (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
7:16 PM
Sandborn William J. (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
7:18 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
7:20 PM
Nuss John (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
7:23 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
2:37 PM
Mohan Raju (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2023
12:42 PM
Krueger Christopher W (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2023
10:57 AM
Sandborn William J. (Reporting)
Ventyx Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VTYX) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners